SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave
- PMID: 38443618
- PMCID: PMC10914718
- DOI: 10.1038/s41598-024-55477-9
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave
Abstract
Data on the SARS-CoV-2 infection among primary health care workers (PHCWs) are scarce but essential to reflect on policy regarding prevention and control measures. We assessed the prevalence of PHCWs who have been infected by SARS-CoV-2 in comparison with modeling from the general population in metropolitan France, and associated factors. A cross-sectional study was conducted among general practitioners (GPs), pediatricians, dental and pharmacy workers in primary care between May and August 2021. Participants volunteered to provide a dried-blood spot for SARS-CoV-2 antibody assessment and completed a questionnaire. The primary outcome was defined as the detection of infection-induced antibodies (anti-nucleocapsid IgG, and for non-vaccinees: anti-Spike IgG and neutralizing antibodies) or previous self-reported infection (positive RT-qPCR or antigenic test, or positive ELISA test before vaccination). Estimates were adjusted using weights for representativeness and compared with prediction from the general population. Poisson regressions were used to quantify associated factors. The analysis included 1612 PHCWs. Weighted prevalences were: 31.7% (95% CI 27.5-36.0) for GPs, 28.7% (95% CI 24.4-33.0) for pediatricians, 25.2% (95% CI 20.6-31.0) for dentists, and 25.5% (95% CI 18.2-34.0) for pharmacists. Estimates were compatible with model predictions for the general population. PHCWs more likely to be infected were: GPs compared to pharmacist assistants (adjusted prevalence ratio [aPR] = 2.26; CI 95% 1.01-5.07), those living in Île-de-France (aPR = 1.53; CI 95% 1.14-2.05), South-East (aPR = 1.57; CI 95% 1.19-2.08), North-East (aPR = 1.81; CI 95% 1.38-2.37), and those having an unprotected contact with a COVID-19 case within the household (aPR = 1.48; CI 95% 1.22-1.80). Occupational factors were not associated with infection. In conclusion, the risk of SARS-CoV-2 exposure for PHCWs was more likely to have occurred in the community rather than at their workplace.
Keywords: COVID-19; General population; Healthcare workers; Prevalence; Primary healthcare; Risk factors; SARS-CoV-2.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol.Pathogens. 2021 Jul 20;10(7):911. doi: 10.3390/pathogens10070911. Pathogens. 2021. PMID: 34358061 Free PMC article.
-
Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers.Int J Infect Dis. 2021 Apr;105:474-481. doi: 10.1016/j.ijid.2021.03.017. Epub 2021 Mar 12. Int J Infect Dis. 2021. PMID: 33722686 Free PMC article.
-
Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France.Viruses. 2022 May 3;14(5):957. doi: 10.3390/v14050957. Viruses. 2022. PMID: 35632699 Free PMC article.
-
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.Front Public Health. 2022 Oct 6;10:967447. doi: 10.3389/fpubh.2022.967447. eCollection 2022. Front Public Health. 2022. PMID: 36276377 Free PMC article.
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
Cited by
-
Risk of SARS-CoV-2 infection before and after the Omicron wave in a cohort of healthcare workers in Ontario, Canada.BMC Infect Dis. 2025 Feb 7;25(1):183. doi: 10.1186/s12879-025-10580-8. BMC Infect Dis. 2025. PMID: 39920611 Free PMC article.
-
SARS-CoV-2 anti-N antibodies among healthcare personnel without previous known COVID-19.Antimicrob Steward Healthc Epidemiol. 2024 Oct 22;4(1):e184. doi: 10.1017/ash.2024.389. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 39450093 Free PMC article.
-
Use of cell phone data to correct Île-de-France population estimates and SARS-CoV-2 incidence, July to September, 2021: a proof-of-concept exercise.Euro Surveill. 2025 Jun;30(22):2400530. doi: 10.2807/1560-7917.ES.2025.30.22.2400530. Euro Surveill. 2025. PMID: 40476291 Free PMC article.
-
Epidemiological characteristics of first-time SARS-CoV-2 Omicron infection among hospital staff in Chengdu, China.J Health Popul Nutr. 2024 Jul 8;43(1):104. doi: 10.1186/s41043-024-00595-3. J Health Popul Nutr. 2024. PMID: 38978145 Free PMC article.
-
The Family Doctor in the "COVID-19 Era".Healthcare (Basel). 2024 Dec 27;13(1):32. doi: 10.3390/healthcare13010032. Healthcare (Basel). 2024. PMID: 39791639 Free PMC article. Review.
References
-
- World Health Organization. The impact of COVID-19 on health and care workers: a closer look at deaths.https://www.who.int/publications/i/item/WHO-HWF-WorkingPaper-2021.1 (Accessed on 8 January 2024).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous